Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Biologics and Biosimilars Market 2018, Forecast to 2023

Publisher Name :
Date: 09-Jun-2018
No. of pages: 150

A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.

Scope of the Report:

This report focuses on the Biologics and Biosimilars in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Most of biologics manufacturer are concentrated in US, Germany,UK and other developed countries. But in biosimilars industry the situation is different, manufacturer in developing countries play a very important role.

Through the research we tend to believe that the growth of biologics industry maybe slow but high profits during the period of patent may attractive. As to biosimilars, now is a changce for newcomers and they will greatly change the industry.

The worldwide market for Biologics and Biosimilars is expected to grow at a CAGR of roughly 5.5% over the next five years, will reach 199600 million US$ in 2023, from 144700 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

- - Roche

- - Amgen

- - AbbVie

- - Sanofi-Aventis

- - Johnson & Johnson

- - Pfizer

- - Novo Nordisk

- - Eli Lilly

- - Novartis

- - Merck

- - 3sbio

- - Changchun High Tech

- - CP Guojian

- - Biotech

- - Gelgen

- - Innovent

- - Dong Bao

- - Ganlee

- - United Laboratories

- - Others

Market Segment by Regions, regional analysis covers

- - North America (United States, Canada and Mexico)

- - Europe (Germany, France, UK, Russia and Italy)

- - Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- - South America (Brazil, Argentina, Colombia etc.)

- - Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- - Antibody

- - Hormone

- - Growth Factors

- - Other

Market Segment by Applications, can be divided into

- - Tumor

- - Diabetes

- - Cardiovascular

- - Hemophilia

- - Other

There are 15 Chapters to deeply display the global Biologics and Biosimilars market.

Chapter 1, to describe Biologics and Biosimilars Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Biologics and Biosimilars, with sales, revenue, and price of Biologics and Biosimilars, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Biologics and Biosimilars, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Biologics and Biosimilars market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Biologics and Biosimilars sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Biologics and Biosimilars Market 2018, Forecast to 2023

Table of Contents

1 Market Overview
1.1 Biologics and Biosimilars Introduction
1.2 Market Analysis by Type
1.2.1 Antibody
1.2.2 Hormone
1.2.3 Growth Factors
1.2.4 Other
1.3 Market Analysis by Applications
1.3.1 Tumor
1.3.2 Diabetes
1.3.3 Cardiovascular
1.3.4 Hemophilia
1.3.5 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Roche
2.1.1 Business Overview
2.1.1.1 Roche Description
2.1.1.2 Roche Headquarter, Main Business and Finance Overview
2.1.2 Roche Biologics and Biosimilars Product Introduction
2.1.2.1 Biologics and Biosimilars Production Bases, Sales Regions and Major Competitors
2.1.2.2 Biologics and Biosimilars Product Information
2.1.3 Roche Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 Roche Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global Roche Biologics and Biosimilars Market Share in 2017
2.2 Amgen
2.2.1 Business Overview
2.2.1.1 Amgen Description
2.2.1.2 Amgen Headquarter, Main Business and Finance Overview
2.2.2 Amgen Biologics and Biosimilars Product Introduction
2.2.2.1 Biologics and Biosimilars Production Bases, Sales Regions and Major Competitors
2.2.2.2 Biologics and Biosimilars Product Information
2.2.3 Amgen Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 Amgen Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global Amgen Biologics and Biosimilars Market Share in 2017
2.3 AbbVie
2.3.1 Business Overview
2.3.1.1 AbbVie Description
2.3.1.2 AbbVie Headquarter, Main Business and Finance Overview
2.3.2 AbbVie Biologics and Biosimilars Product Introduction
2.3.2.1 Biologics and Biosimilars Production Bases, Sales Regions and Major Competitors
2.3.2.2 Biologics and Biosimilars Product Information
2.3.3 AbbVie Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 AbbVie Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global AbbVie Biologics and Biosimilars Market Share in 2017
2.4 Sanofi-Aventis
2.4.1 Business Overview
2.4.1.1 Sanofi-Aventis Description
2.4.1.2 Sanofi-Aventis Headquarter, Main Business and Finance Overview
2.4.2 Sanofi-Aventis Biologics and Biosimilars Product Introduction
2.4.2.1 Biologics and Biosimilars Production Bases, Sales Regions and Major Competitors
2.4.2.2 Biologics and Biosimilars Product Information
2.4.3 Sanofi-Aventis Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 Sanofi-Aventis Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global Sanofi-Aventis Biologics and Biosimilars Market Share in 2017
2.5 Johnson & Johnson
2.5.1 Business Overview
2.5.1.1 Johnson & Johnson Description
2.5.1.2 Johnson & Johnson Headquarter, Main Business and Finance Overview
2.5.2 Johnson & Johnson Biologics and Biosimilars Product Introduction
2.5.2.1 Biologics and Biosimilars Production Bases, Sales Regions and Major Competitors
2.5.2.2 Biologics and Biosimilars Product Information
2.5.3 Johnson & Johnson Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Johnson & Johnson Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Johnson & Johnson Biologics and Biosimilars Market Share in 2017
2.6 Pfizer
2.6.1 Business Overview
2.6.1.1 Pfizer Description
2.6.1.2 Pfizer Headquarter, Main Business and Finance Overview
2.6.2 Pfizer Biologics and Biosimilars Product Introduction
2.6.2.1 Biologics and Biosimilars Production Bases, Sales Regions and Major Competitors
2.6.2.2 Biologics and Biosimilars Product Information
2.6.3 Pfizer Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 Pfizer Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global Pfizer Biologics and Biosimilars Market Share in 2017
2.7 Novo Nordisk
2.7.1 Business Overview
2.7.1.1 Novo Nordisk Description
2.7.1.2 Novo Nordisk Headquarter, Main Business and Finance Overview
2.7.2 Novo Nordisk Biologics and Biosimilars Product Introduction
2.7.2.1 Biologics and Biosimilars Production Bases, Sales Regions and Major Competitors
2.7.2.2 Biologics and Biosimilars Product Information
2.7.3 Novo Nordisk Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 Novo Nordisk Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global Novo Nordisk Biologics and Biosimilars Market Share in 2017
2.8 Eli Lilly
2.8.1 Business Overview
2.8.1.1 Eli Lilly Description
2.8.1.2 Eli Lilly Headquarter, Main Business and Finance Overview
2.8.2 Eli Lilly Biologics and Biosimilars Product Introduction
2.8.2.1 Biologics and Biosimilars Production Bases, Sales Regions and Major Competitors
2.8.2.2 Biologics and Biosimilars Product Information
2.8.3 Eli Lilly Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 Eli Lilly Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global Eli Lilly Biologics and Biosimilars Market Share in 2017
2.9 Novartis
2.9.1 Business Overview
2.9.1.1 Novartis Description
2.9.1.2 Novartis Headquarter, Main Business and Finance Overview
2.9.2 Novartis Biologics and Biosimilars Product Introduction
2.9.2.1 Biologics and Biosimilars Production Bases, Sales Regions and Major Competitors
2.9.2.2 Biologics and Biosimilars Product Information
2.9.3 Novartis Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.1 Novartis Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.2 Global Novartis Biologics and Biosimilars Market Share in 2017
2.10 Merck
2.10.1 Business Overview
2.10.1.1 Merck Description
2.10.1.2 Merck Headquarter, Main Business and Finance Overview
2.10.2 Merck Biologics and Biosimilars Product Introduction
2.10.2.1 Biologics and Biosimilars Production Bases, Sales Regions and Major Competitors
2.10.2.2 Biologics and Biosimilars Product Information
2.10.3 Merck Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.1 Merck Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.2 Global Merck Biologics and Biosimilars Market Share in 2017
2.11 3sbio
2.11.1 Business Overview
2.11.2 3sbio Biologics and Biosimilars Product Introduction
2.11.3 3sbio Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Changchun High Tech
2.12.1 Business Overview
2.12.2 Changchun High Tech Biologics and Biosimilars Product Introduction
2.12.3 Changchun High Tech Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 CP Guojian
2.13.1 Business Overview
2.13.2 CP Guojian Biologics and Biosimilars Product Introduction
2.13.3 CP Guojian Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Biotech
2.14.1 Business Overview
2.14.2 Biotech Biologics and Biosimilars Product Introduction
2.14.3 Biotech Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Gelgen
2.15.1 Business Overview
2.15.2 Gelgen Biologics and Biosimilars Product Introduction
2.15.3 Gelgen Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Innovent
2.16.1 Business Overview
2.16.2 Innovent Biologics and Biosimilars Product Introduction
2.16.3 Innovent Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 Dong Bao
2.17.1 Business Overview
2.17.2 Dong Bao Biologics and Biosimilars Product Introduction
2.17.3 Dong Bao Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.18 Ganlee
2.18.1 Business Overview
2.18.2 Ganlee Biologics and Biosimilars Product Introduction
2.18.3 Ganlee Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.19 United Laboratories
2.19.1 Business Overview
2.19.2 United Laboratories Biologics and Biosimilars Product Introduction
2.19.3 United Laboratories Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.20 Others
2.20.1 Business Overview
2.20.2 Others Biologics and Biosimilars Product Introduction
2.20.3 Others Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Biologics and Biosimilars Market Competition, by Manufacturer
3.1 Global Biologics and Biosimilars Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Biologics and Biosimilars Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Biologics and Biosimilars Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Biologics and Biosimilars Manufacturer Market Share in 2017
3.4.2 Top 5 Biologics and Biosimilars Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 Global Biologics and Biosimilars Market Analysis by Regions
4.1 Global Biologics and Biosimilars Sales, Revenue and Market Share by Regions
4.1.1 Global Biologics and Biosimilars Sales by Regions (2013-2018)
4.1.2 Global Biologics and Biosimilars Revenue by Regions (2013-2018)
4.2 North America Biologics and Biosimilars Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Biologics and Biosimilars Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Biologics and Biosimilars Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Biologics and Biosimilars Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Biologics and Biosimilars Sales, Revenue and Growth Rate (2013-2018)
5 North America Biologics and Biosimilars by Countries, Type, Application and Manufacturers
5.1 North America Biologics and Biosimilars Sales, Revenue and Market Share by Countries
5.1.1 North America Biologics and Biosimilars Sales by Countries (2013-2018)
5.1.2 North America Biologics and Biosimilars Revenue by Countries (2013-2018)
5.1.3 United States Biologics and Biosimilars Sales and Growth Rate (2013-2018)
5.1.4 Canada Biologics and Biosimilars Sales and Growth Rate (2013-2018)
5.1.5 Mexico Biologics and Biosimilars Sales and Growth Rate (2013-2018)
5.2 North America Biologics and Biosimilars Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Biologics and Biosimilars Sales by Manufacturers (2016-2017)
5.2.2 North America Biologics and Biosimilars Revenue by Manufacturers (2016-2017)
5.3 North America Biologics and Biosimilars Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Biologics and Biosimilars Sales and Sales Share by Type (2013-2018)
5.3.2 North America Biologics and Biosimilars Revenue and Revenue Share by Type (2013-2018)
5.4 North America Biologics and Biosimilars Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Biologics and Biosimilars Sales and Sales Share by Application (2013-2018)
5.4.2 North America Biologics and Biosimilars Revenue and Revenue Share by Application (2013-2018)
6 Europe Biologics and Biosimilars by Countries, Type, Application and Manufacturers
6.1 Europe Biologics and Biosimilars Sales, Revenue and Market Share by Countries
6.1.1 Europe Biologics and Biosimilars Sales by Countries (2013-2018)
6.1.2 Europe Biologics and Biosimilars Revenue by Countries (2013-2018)
6.1.3 Germany Biologics and Biosimilars Sales and Growth Rate (2013-2018)
6.1.4 UK Biologics and Biosimilars Sales and Growth Rate (2013-2018)
6.1.5 France Biologics and Biosimilars Sales and Growth Rate (2013-2018)
6.1.6 Russia Biologics and Biosimilars Sales and Growth Rate (2013-2018)
6.1.7 Italy Biologics and Biosimilars Sales and Growth Rate (2013-2018)
6.2 Europe Biologics and Biosimilars Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Biologics and Biosimilars Sales by Manufacturers (2016-2017)
6.2.2 Europe Biologics and Biosimilars Revenue by Manufacturers (2016-2017)
6.3 Europe Biologics and Biosimilars Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Biologics and Biosimilars Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Biologics and Biosimilars Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Biologics and Biosimilars Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Biologics and Biosimilars Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Biologics and Biosimilars Revenue and Revenue Share by Application (2013-2018)
7 Asia-Pacific Biologics and Biosimilars by Countries, Type, Application and Manufacturers
7.1 Asia-Pacific Biologics and Biosimilars Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Biologics and Biosimilars Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Biologics and Biosimilars Revenue by Countries (2013-2018)
7.1.3 China Biologics and Biosimilars Sales and Growth Rate (2013-2018)
7.1.4 Japan Biologics and Biosimilars Sales and Growth Rate (2013-2018)
7.1.5 Korea Biologics and Biosimilars Sales and Growth Rate (2013-2018)
7.1.6 India Biologics and Biosimilars Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Biologics and Biosimilars Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Biologics and Biosimilars Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Biologics and Biosimilars Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Biologics and Biosimilars Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Biologics and Biosimilars Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Biologics and Biosimilars Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Biologics and Biosimilars Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Biologics and Biosimilars Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Biologics and Biosimilars Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Biologics and Biosimilars Revenue and Revenue Share by Application (2013-2018)
8 South America Biologics and Biosimilars by Countries, Type, Application and Manufacturers
8.1 South America Biologics and Biosimilars Sales, Revenue and Market Share by Countries
8.1.1 South America Biologics and Biosimilars Sales by Countries (2013-2018)
8.1.2 South America Biologics and Biosimilars Revenue by Countries (2013-2018)
8.1.3 Brazil Biologics and Biosimilars Sales and Growth Rate (2013-2018)
8.1.4 Argentina Biologics and Biosimilars Sales and Growth Rate (2013-2018)
8.1.5 Colombia Biologics and Biosimilars Sales and Growth Rate (2013-2018)
8.2 South America Biologics and Biosimilars Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Biologics and Biosimilars Sales by Manufacturers (2016-2017)
8.2.2 South America Biologics and Biosimilars Revenue by Manufacturers (2016-2017)
8.3 South America Biologics and Biosimilars Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Biologics and Biosimilars Sales and Sales Share by Type (2013-2018)
8.3.2 South America Biologics and Biosimilars Revenue and Revenue Share by Type (2013-2018)
8.4 South America Biologics and Biosimilars Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Biologics and Biosimilars Sales and Sales Share by Application (2013-2018)
8.4.2 South America Biologics and Biosimilars Revenue and Revenue Share by Application (2013-2018)
9 Middle East and Africa Biologics and Biosimilars by Countries, Type, Application and Manufacturers
9.1 Middle East and Africa Biologics and Biosimilars Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Biologics and Biosimilars Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Biologics and Biosimilars Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Biologics and Biosimilars Sales and Growth Rate (2013-2018)
9.1.4 UAE Biologics and Biosimilars Sales and Growth Rate (2013-2018)
9.1.5 Egypt Biologics and Biosimilars Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Biologics and Biosimilars Sales and Growth Rate (2013-2018)
9.1.7 South Africa Biologics and Biosimilars Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Biologics and Biosimilars Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Biologics and Biosimilars Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Biologics and Biosimilars Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Biologics and Biosimilars Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Biologics and Biosimilars Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Biologics and Biosimilars Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Biologics and Biosimilars Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Biologics and Biosimilars Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Biologics and Biosimilars Revenue and Revenue Share by Application (2013-2018)
10 Global Biologics and Biosimilars Market Segment by Type
10.1 Global Biologics and Biosimilars Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Biologics and Biosimilars Sales and Market Share by Type (2013-2018)
10.1.2 Global Biologics and Biosimilars Revenue and Market Share by Type (2013-2018)
10.2 Antibody Sales Growth and Price
10.2.1 Global Antibody Sales Growth (2013-2018)
10.2.2 Global Antibody Price (2013-2018)
10.3 Hormone Sales Growth and Price
10.3.1 Global Hormone Sales Growth (2013-2018)
10.3.2 Global Hormone Price (2013-2018)
10.4 Growth Factors Sales Growth and Price
10.4.1 Global Growth Factors Sales Growth (2013-2018)
10.4.2 Global Growth Factors Price (2013-2018)
10.5 Other Sales Growth and Price
10.5.1 Global Other Sales Growth (2013-2018)
10.5.2 Global Other Price (2013-2018)
11 Global Biologics and Biosimilars Market Segment by Application
11.1 Global Biologics and Biosimilars Sales Market Share by Application (2013-2018)
11.2 Tumor Sales Growth (2013-2018)
11.3 Diabetes Sales Growth (2013-2018)
11.4 Cardiovascular Sales Growth (2013-2018)
11.5 Hemophilia Sales Growth (2013-2018)
11.6 Other Sales Growth (2013-2018)
12 Biologics and Biosimilars Market Forecast (2018-2023)
12.1 Global Biologics and Biosimilars Sales, Revenue and Growth Rate (2018-2023)
12.2 Biologics and Biosimilars Market Forecast by Regions (2018-2023)
12.2.1 North America Biologics and Biosimilars Market Forecast (2018-2023)
12.2.2 Europe Biologics and Biosimilars Market Forecast (2018-2023)
12.2.3 Asia-Pacific Biologics and Biosimilars Market Forecast (2018-2023)
12.2.4 South America Biologics and Biosimilars Market Forecast (2018-2023)
12.2.5 Middle East and Africa Biologics and Biosimilars Market Forecast (2018-2023)
12.3 Biologics and Biosimilars Market Forecast by Type (2018-2023)
12.3.1 Global Biologics and Biosimilars Sales Forecast by Type (2018-2023)
12.3.2 Global Biologics and Biosimilars Market Share Forecast by Type (2018-2023)
12.4 Biologics and Biosimilars Market Forecast by Application (2018-2023)
12.4.1 Global Biologics and Biosimilars Sales Forecast by Application (2018-2023)
12.4.2 Global Biologics and Biosimilars Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source


List of Tables and Figures

Figure Biologics and Biosimilars Picture
Table Product Specifications of Biologics and Biosimilars
Figure Global Biologics and Biosimilars CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Biologics and Biosimilars CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Biologics and Biosimilars by Types in 2017
Figure Antibody Picture
Table Major Manufacturers of Antibody
Figure Hormone Picture
Table Major Manufacturers of Hormone
Figure Growth Factors Picture
Table Major Manufacturers of Growth Factors
Figure Other Picture
Table Major Manufacturers of Other
Figure Biologics and Biosimilars Sales Market Share by Applications in 2017
Figure Tumor Picture
Figure Diabetes Picture
Figure Cardiovascular Picture
Figure Hemophilia Picture
Figure Other Picture
Figure United States Biologics and Biosimilars Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Biologics and Biosimilars Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Biologics and Biosimilars Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Biologics and Biosimilars Revenue (Value) and Growth Rate (2013-2023)
Figure France Biologics and Biosimilars Revenue (Value) and Growth Rate (2013-2023)
Figure UK Biologics and Biosimilars Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Biologics and Biosimilars Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Biologics and Biosimilars Revenue (Value) and Growth Rate (2013-2023)
Figure China Biologics and Biosimilars Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Biologics and Biosimilars Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Biologics and Biosimilars Revenue (Value) and Growth Rate (2013-2023)
Figure India Biologics and Biosimilars Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Biologics and Biosimilars Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Biologics and Biosimilars Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Biologics and Biosimilars Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Biologics and Biosimilars Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Biologics and Biosimilars Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Biologics and Biosimilars Revenue (Value) and Growth Rate (2013-2023)
Table Roche Headquarter, Established, Main Business and Finance Overview (2017)
Table Roche Biologics and Biosimilars Production Bases, Sales Regions and Major Competitors
Table Roche Biologics and Biosimilars Product
Table Roche Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Roche Biologics and Biosimilars Sales Market Share in 2017
Figure Global Roche Biologics and Biosimilars Revenue Market Share in 2017
Table Amgen Headquarter, Established, Main Business and Finance Overview (2017)
Table Amgen Biologics and Biosimilars Production Bases, Sales Regions and Major Competitors
Table Amgen Biologics and Biosimilars Product
Table Amgen Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Amgen Biologics and Biosimilars Sales Market Share in 2017
Figure Global Amgen Biologics and Biosimilars Revenue Market Share in 2017
Table AbbVie Headquarter, Established, Main Business and Finance Overview (2017)
Table AbbVie Biologics and Biosimilars Production Bases, Sales Regions and Major Competitors
Table AbbVie Biologics and Biosimilars Product
Table AbbVie Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global AbbVie Biologics and Biosimilars Sales Market Share in 2017
Figure Global AbbVie Biologics and Biosimilars Revenue Market Share in 2017
Table Sanofi-Aventis Headquarter, Established, Main Business and Finance Overview (2017)
Table Sanofi-Aventis Biologics and Biosimilars Production Bases, Sales Regions and Major Competitors
Table Sanofi-Aventis Biologics and Biosimilars Product
Table Sanofi-Aventis Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Sanofi-Aventis Biologics and Biosimilars Sales Market Share in 2017
Figure Global Sanofi-Aventis Biologics and Biosimilars Revenue Market Share in 2017
Table Johnson & Johnson Headquarter, Established, Main Business and Finance Overview (2017)
Table Johnson & Johnson Biologics and Biosimilars Production Bases, Sales Regions and Major Competitors
Table Johnson & Johnson Biologics and Biosimilars Product
Table Johnson & Johnson Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Johnson & Johnson Biologics and Biosimilars Sales Market Share in 2017
Figure Global Johnson & Johnson Biologics and Biosimilars Revenue Market Share in 2017
Table Pfizer Headquarter, Established, Main Business and Finance Overview (2017)
Table Pfizer Biologics and Biosimilars Production Bases, Sales Regions and Major Competitors
Table Pfizer Biologics and Biosimilars Product
Table Pfizer Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Pfizer Biologics and Biosimilars Sales Market Share in 2017
Figure Global Pfizer Biologics and Biosimilars Revenue Market Share in 2017
Table Novo Nordisk Headquarter, Established, Main Business and Finance Overview (2017)
Table Novo Nordisk Biologics and Biosimilars Production Bases, Sales Regions and Major Competitors
Table Novo Nordisk Biologics and Biosimilars Product
Table Novo Nordisk Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Novo Nordisk Biologics and Biosimilars Sales Market Share in 2017
Figure Global Novo Nordisk Biologics and Biosimilars Revenue Market Share in 2017
Table Eli Lilly Headquarter, Established, Main Business and Finance Overview (2017)
Table Eli Lilly Biologics and Biosimilars Production Bases, Sales Regions and Major Competitors
Table Eli Lilly Biologics and Biosimilars Product
Table Eli Lilly Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Eli Lilly Biologics and Biosimilars Sales Market Share in 2017
Figure Global Eli Lilly Biologics and Biosimilars Revenue Market Share in 2017
Table Novartis Headquarter, Established, Main Business and Finance Overview (2017)
Table Novartis Biologics and Biosimilars Production Bases, Sales Regions and Major Competitors
Table Novartis Biologics and Biosimilars Product
Table Novartis Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Novartis Biologics and Biosimilars Sales Market Share in 2017
Figure Global Novartis Biologics and Biosimilars Revenue Market Share in 2017
Table Merck Headquarter, Established, Main Business and Finance Overview (2017)
Table Merck Biologics and Biosimilars Production Bases, Sales Regions and Major Competitors
Table Merck Biologics and Biosimilars Product
Table Merck Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Merck Biologics and Biosimilars Sales Market Share in 2017
Figure Global Merck Biologics and Biosimilars Revenue Market Share in 2017
Table 3sbio
Table 3sbio Biologics and Biosimilars
Table Changchun High Tech
Table Changchun High Tech Biologics and Biosimilars
Table CP Guojian
Table CP Guojian Biologics and Biosimilars
Table Biotech
Table Biotech Biologics and Biosimilars
Table Gelgen
Table Gelgen Biologics and Biosimilars
Table Innovent
Table Innovent Biologics and Biosimilars
Table Dong Bao
Table Dong Bao Biologics and Biosimilars
Table Ganlee
Table Ganlee Biologics and Biosimilars
Table United Laboratories
Table United Laboratories Biologics and Biosimilars
Table Others
Table Others Biologics and Biosimilars
Table Global Biologics and Biosimilars Sales by Manufacturer (2016-2017)
Figure Global Biologics and Biosimilars Sales Market Share by Manufacturer in 2016
Figure Global Biologics and Biosimilars Sales Market Share by Manufacturer in 2017
Table Global Biologics and Biosimilars Revenue by Manufacturer (2016-2017)
Figure Global Biologics and Biosimilars Revenue Market Share by Manufacturer in 2016
Figure Global Biologics and Biosimilars Revenue Market Share by Manufacturer in 2017
Table Global Biologics and Biosimilars Price by Manufacturer (2016-2017)
Figure Top 3 Biologics and Biosimilars Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Biologics and Biosimil
  • Global Biosimilar Drug Market by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 10-Jun-2018        Price: US 3480 Onwards        Pages: 133
    Biosimilar drug is medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilar drug are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodys drugs production by bio-engineered technology, but does not include a vaccine. Scope of the Report: This report focuses on the Biosimilar Drug in global market, especial......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Biosimilar Drug Market 2018, Forecast to 2023
    Published: 10-Jun-2018        Price: US 4880 Onwards        Pages: 132
    Biosimilar drug is medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilar drug are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodys drugs production by bio-engineered technology, but does not include a vaccine. Scope of the Report: This report focuses on the Biosimilar Drug in global market, especial......
  • Global Biologics and Biosimilars Market by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 09-Jun-2018        Price: US 3480 Onwards        Pages: 154
    A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine. Scope of the Report: This report focuses on the Biologics and Biosimilars in global market, espe......
  • Global and China Adalimumab Biosimilar Market Research by Company, Type & Application 2013-2025
    Published: 25-May-2018        Price: US 2000 Onwards        Pages: 78
    Summary Market Segment as follows: By Type - Tablet - Oral Solution By Application - Hospital Pharmacy - Retail Pharmacy - Online Pharmacy By Company - AET BioTech - Amgen - Boehringer Ingelheim - Coherus Biosciences - Fujifilm Kyowa Kirin Biologics - LG Life Sciences/Mochida Pharmaceutical - Momenta Pharmaceuticals - Oncobiologics - Pfize......
  • United States Biosimilar Monoclonal Antibodies Market Report 2018
    Published: 23-May-2018        Price: US 3800 Onwards        Pages: 105
    In this report, the United States Biosimilar Monoclonal Antibodies market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share an......
  • Global Biosimilar Monoclonal Antibodies Market Research Report 2018
    Published: 18-May-2018        Price: US 2900 Onwards        Pages: 110
    This report studies the global Biosimilar Monoclonal Antibodies market status and forecast, categorizes the global Biosimilar Monoclonal Antibodies market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa. In 2017, the global Biosimilar Monoclonal Antibodies market size was xx million US$ and it is expected to reach xx million US$ by the end of ......
  • Global Oncology Biosimilars Market Data Survey Report 2025
    Published: 22-Apr-2018        Price: US 1500 Onwards        Pages: 80
    Summary The global Oncology Biosimilars market will reach Volume Million USD in 2018 with CAGR xx% 2018-2025. The main contents of the report including: Global market size and forecast Regional market size, production data and export & import Key manufacturers (manufacturing sites, capacity and production, product specifications etc.) Major Application Major Type Key manufacturers are included based on manufacturing sites, capacity......
  • Global and United States Biologics and Biosimilars Market Research by Company, Type & Application 2013-2025
    Published: 20-Apr-2018        Price: US 2000 Onwards        Pages: 120
    Summary A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.A biosimilar in this report is a biologic medical product which is copy of an original product t......
  • Global and United States Biosimilars Market Research by Company, Type & Application 2013-2025
    Published: 20-Apr-2018        Price: US 2000 Onwards        Pages: 90
    Summary A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product which is almost an identical copy of an original product that is manufactured by a different company. Market Segment as follows: By Type - Injection - Tablets - Others By Application - Ankylosing Spondylitis - Tumor - Rheumatoid Arthrtis - Cardiovascular By Company - S......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs